Amid market resilience, Deven Choksey anticipates Nifty potentially reaching 25,200, with corrections offering buying opportunities. He suggests IT, pharmaceuticals, and metals could drive market momentum, favoring large-cap stocks over mid and small-caps. Controlled input costs and improved capital goods demand may benefit manufacturing, with selective buying advised in IT and pharma stocks.
Positive Breakout: 7 stocks cross above their 200 DMAs
In the Nifty200 pack, seven stocks’ closing prices crossed above their 200-day moving averages (DMA) on October 29, 2026, according to StockEdge’s technical scan data.